The Society for Maternal-Fetal Medicine | Strategic Alliance Partners

View the latest recommendations from the Society for Maternal-Fetal Medicine on anticoagulation in pregnant patients with cardiac disease.

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.

From SMFM, a visual summary of Consult #60.

This Consult discusses the management of pregnancies achieved with in vitro fertilization and provides recommendations based on the available evidence.

This Consult has been endorsed by the American College of Obstetricians and Gynecologists (ACOG) and replaces the Society for Maternal-Fetal Medicine's (SMFM) Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.

Get the Facts. Get Vaccinated.

Effective each year on October 1, additions, deletions, and updates to the ICD-10-CM code set are published. This year, no significant changes were made to Chapter 15, the obstetrics chapter. However, there are a few new codes that could affect the practice of maternal-fetal medicine.

An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.

Researchers presented their oral abstract on the association between lactation and the gut microbiome during the SMFM 42nd Annual Pregnancy Meeting.

SMFM supports the new NIH COVID-19 Treatment guidelines.

The Society for Maternal-Fetal Medicine has announced its upcoming 2022 annual meeting will now be virtual.

The Society for Maternal-Fetal Medicine has published an update for provider considerations for COVID-19 vaccine counseling with pregnant or lactating patients.

Pregnant? Thinking about pregnancy? Recently pregnant? Check out the top 5 reasons to get the COVID-19 vaccine from the Society for Maternal-Fetal Medicine.

Patients Desiring Immediate Postpartum Sterilization Should Not Be Required to Wait 30 Days.

SMFM Consult Series #56: Hepatitis C in pregnancy: updated screening, treatment, and management guidelines.

Download a visual summary of SMFM Consult Series #56: Hepatitis C in pregnancy: updated guidelines

Registration is now open for the Society for Maternal-Fetal Medicine's (SMFM) 42nd Annual Pregnancy Meeting, to be held from January 31 to February 5, 2022, at the Gaylord Palms Resort and Convention Center near Orlando, Florida.

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

The path to transformational leadership.

The course will cover a range of high-risk OB topics with an emphasis on clinical management, in the form of lectures, case presentations, panel discussions and audience participation.

Refer to this visual summary from SMFM wherever you practice.

Intrahepatic cholestasis of pregnancy (ICP) occurs in the second and third trimesters of pregnancy and is characterized by pruritus and elevated serum bile acid concentrations.

This year’s annual meeting of the Society for Maternal-Fetal Medicine (SMFM) will go down in history as one to remember.

A challenge in the prenatal management of FGR is differentiating the constitutionally small fetus with a normal neonatal outcome from one who is pathologically growth restricted and at risk for postnatal complications.

Florida’s Pregnancy Related Mortality Ratio (PRMR) shows a significant decrease in pregnancy-related mortality rates among Hispanic and non-Hispanic Black women, according to a study presented at SMFM’s 2021 Virtual Annual Meeting.

“Whatever you do for me but without me, you do against me.” That was the theme of a scientific forum on Wednesday titled, “Practicing equitable global health,” as part of SMFM’s 2021 Virtual Annual Meeting.

Loïc Sentilhes, MD, PHD, presented data on tranexamic acid (TXA) for the prevention of postpartum hemorrhage after cesarean delivery: the TRAAP2 trial, on Wednesday at SMFM's 2021 Virtual Annual Meeting.

Kacey Eichelberger, MD, presented recent data on the disparities in maternal outcomes of non-Hispanic Black women on Tuesday at SMFM's 2021 Virtual Annual Meeting.

The Society for Maternal-Fetal Medicine (SMFM) is encouraging all its members to weave advocacy for maternal health and lives into their everyday work, even with the smallest steps, during its 41st Annual Pregnancy Meeting, being held virtually this week.

Three experts in maternal-fetal medicine hosted the Womxn’s Health Collaborative Symposium: Crucial conversations for careers in MFM during the Society for Maternal Fetal Medicine’s (SMFM) 41st Annual Pregnancy Meeting on Monday.